Toggle navigation
Home
Search
Services
Blog
Contact
About
Phase II Clinical Trials of New Chemopreventive Agents
Carbone, Paul P.
University of Wisconsin Madison, Madison, WI, United States
Search 104 grants from Paul Carbone
Search grants from University of Wisconsin Madison
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Publications
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Nanosecond Temperature-Jump Saxs
Concentration-Controlled Ribavirin for the Treatment of Patients with Chronic HVC
Mouse Core
Heat Shock and Steroid Receptor Signaling
Treatment Program Critical Populations
Recently added grants:
Huntsman Cancer Institute/ University of Utah Network Lead Academic Participating Site Application
The role and regulation of Hippo pathway in sarcomagenesis
NCTN Lead Academic Participating Site at Dana-Farber/Partners Cancer Care
Network Lead Academic Participating Site Grant from the Roswell Park Cancer Institute
The role of MIF in mitochondrial metabolism and M2-TAM polarization
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
Division of Cancer Prevention And Control (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CN025434-001003
Application #
6031055
Study Section
Project Start
1993-06-15
Project End
2002-09-15
Budget Start
1998-09-15
Budget End
2002-09-15
Support Year
Fiscal Year
1999
Total Cost
Indirect Cost
Institution
Name
University of Wisconsin Madison
Department
Type
Schools of Medicine
DUNS #
161202122
City
Madison
State
WI
Country
United States
Zip Code
53715
Related projects
NIH 1999
N01 CN
Phase II Clinical Trials of New Chemopreventive Agents
Carbone, Paul P. / University of Wisconsin Madison
NIH 1997
N01 CN
Phase II Clinical Trials of New Chemopreventive Agents
Carbone, Paul P. / University of Wisconsin Madison
NIH 1996
N01 CN
Phase II Clinical Trials of New Chemopreventive Agents
Carbone, Paul P. / University of Wisconsin Madison
NIH 1993
N01 CN
Phase II Clinical Trials of New Chemopreventive Agents
Messing, E. / University of Wisconsin Madison
Publications
Messing, Edward; Kim, Kyung Mann; Sharkey, Francis et al.
(2006)
Randomized prospective phase III trial of difluoromethylornithine vs placebo in preventing recurrence of completely resected low risk superficial bladder cancer.
J Urol 176:500-4
Comments
Be the first to comment on Paul Carbone's grant